Clinical and immunohistochemical findings of splenic mast cell tumour in a cat: A case report

https://doi.org/10.17221/11/2021-VETMEDCitation:

Lee S, Kang MS, Jeong Y, Kim Y, Kwak HH, Choi EW, Choi S, Park I, Chung JY, Choi JH, Ahn JO (2021): Clinical and immunohistochemical findings of splenic mast cell tumour in a cat: A case report. Vet Med-Czech 66, 498–502.

download PDF

A 6-year-old, spayed, female, domestic shorthair cat presented with a 4-month history of chronic intermittent vomiting and anorexia. The haematologic results indicated moderate anaemia and a circulating mast cell population. The abdominal radiography revealed a markedly enlarged spleen. The cytological analysis of the spleen showed a uniform population of mast cells, and a diagnosis of systemic mastocytosis (splenic mast cell tumour with mastocytaemia) was made. This diagnosis was subsequently confirmed by the histopathological examination of the spleen. The immunohistochemistry for KIT showed KIT pattern II (focal cytoplasmic expression). A splenectomy and chemotherapy with vinblastine and prednisolone resulted in remission of the anaemia and other clinical signs. This case report highlights the importance of cytological evaluations of peripheral blood smears and/or aspirates of enlarged spleens for diagnosing splenic mast cell tumours and for quickly initiating the appropriate treatment.

References:
Allan R, Halsey T, Thompson K. Splenic mast cell tumour and mastocytaemia in a cat: Case study and literature review. N Z Vet J. 2000 Aug;48(4):117-21. https://doi.org/10.1080/00480169.2000.36176
 
Evans BJ, O’Brien D, Allstadt SD, Gregor TP, Sorenmo KU. Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi-institutional retrospective study of 64 cases. Vet Comp Oncol. 2018 Mar;16(1):20-7. https://doi.org/10.1111/vco.12305
 
Henry C, Herrera C. Mast cell tumors in cats: Clinical update and possible new treatment avenues. J Feline Med Surg. 2013 Jan;15(1):41-7. https://doi.org/10.1177/1098612X12470343
 
Isotani M, Tamura K, Yagihara H, Hikosaka M, Ono K, Washizu T, Bonkobara M. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Vet Immunol Immunopathol. 2006 Nov 15;114(1-2):168-72. https://doi.org/10.1016/j.vetimm.2006.07.004
 
Kiupel M, Webster J, Kaneene J, Miller R, Yuzbasiyan-Gurkan V. The use of kit and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol. 2004 Jul;41(4):371-7. https://doi.org/10.1354/vp.41-4-371
 
Kraus KA, Clifford CA, Davis GJ, Kiefer KM, Drobatz KJ. Outcome and prognostic indicators in cats undergoing splenectomy for splenic mast cell tumors. J Am Anim Hosp Assoc. 2015 Jul-Aug;51(4):231-8. https://doi.org/10.5326/JAAHA-MS-6280
 
Mallett C, Northrup N, Saba C, Rodriguez C, Rassnick K, Gieger T, Childress M, Howerth E. Immunohistochemical characterization of feline mast cell tumors. Vet Pathol. 2013 Jan;50(1):106-9. https://doi.org/10.1177/0300985812441032
 
Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res. 2006 Feb;34(2):97-115. https://doi.org/10.1385/IR:34:2:97
 
Piviani M, Walton RM, Patel RT. Significance of mastocytemia in cats. Vet Clin Pathol. 2013 Mar;42(1):4-10. https://doi.org/10.1111/vcp.12021
 
Sabattini S, Barzon G, Giantin M, Lopparelli RM, Dacasto M, Prata D, Bettini G. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours. Vet Comp Oncol. 2017 Sep;15(3):1051-61. https://doi.org/10.1111/vco.12246
 
Sabattini S, Bettini G. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors. Vet Pathol. 2010 Jul;47(4):643-53. https://doi.org/10.1177/0300985810364509
 
Sabattini S, Frizzon MG, Gentilini F, Turba M, Capitani O, Bettini G. Prognostic significance of kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors. Vet Pathol. 2013 Sep;50(5):797-805. https://doi.org/10.1177/0300985813476064
 
Sabattini S, Giantin M, Barbanera A, Zorro Shahidian L, Dacasto M, Zancanella V, Prata D, Trivigno E, Bettini G. Feline intestinal mast cell tumours: Clinicopathological characterisation and kit mutation analysis. J Feline Med Surg. 2016 Apr;18(4):280-9. https://doi.org/10.1177/1098612X15581205
 
Skeldon NC, Gerber KL, Wilson RJ, Cunnington SJ. Mastocytaemia in cats: Prevalence, detection and quantification methods, haematological associations and potential implications in 30 cats with mast cell tumours. J Feline Med Surg. 2010 Dec;12(12):960-6. https://doi.org/10.1016/j.jfms.2010.08.003
 
Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, Miller R, Resau JH, Kiupel M. The role of c-kit in tumorigenesis: Evaluation in canine cutaneous mast cell tumors. Neoplasia. 2006 Feb;8(2):104-11. https://doi.org/10.1593/neo.05622
 
Woldemeskel M, Merrill A, Brown C. Significance of cytological smear evaluation in diagnosis of splenic mast cell tumor-associated systemic mastocytosis in a cat (Felis catus). Can Vet J. 2017 Mar;58(3):293-5.
 
download PDF

© 2021 Czech Academy of Agricultural Sciences | Prohlášení o přístupnosti